Aduro Biotech Announces Upcoming Presentations at AACR Annual Meeting 2019

On February 28, 2019 Aduro Biotech, Inc. (NASDAQ: ADRO) reported that three abstracts will be presented at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2019, which will be held from March 29 through April 3, 2019 in Atlanta, GA (Press release, Aduro Biotech, FEB 28, 2019, View Source;p=RssLanding&cat=news&id=2389463 [SID1234533780]). Presentations will highlight the company’s lead programs, STING agonist ADU-S100, and anti-APRIL antibody BION-1301.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the presentations are as follows:


Abstract 1202: Tumor cell intrinsic STING signaling demonstrates minimal contribution to the anti-tumor response elicited by the STING agonist ADU-S100 (MIW815)

Session: Tumor-immune Interactions
Date/Time: Monday Apr 1, 2019 8:00 AM – 12:00 PM
Location: Georgia World Congress Center, Exhibit Hall B, Poster Section 9

Abstract CT107: Phase 1/2 Safety and Pharmacokinetics of BION-1301 Targeting APRIL, a Proliferation-Inducing Ligand, in Adults with Relapsed or Refractory Multiple Myeloma

Session: Phase I-III Trials in Progress: Part 1
Date/Time: Monday Apr 1, 2019 1:00 PM – 5:00 PM
Location: Georgia World Congress Center, Exhibit Hall B, Poster Section 17

Abstract 1203: Preclinical development of ADU-1805, a highly selective pan-allele anti-SIRPα antibody that blocks the SIRPα-CD47 innate immune checkpoint

Session: Tumor-immune Interactions
Date/Time: Monday, Apr 1, 2019 8:00 AM – 12:00 PM
Location: Georgia World Congress Center, Exhibit Hall B, Poster Section 9

To view these abstracts, please visit the AACR (Free AACR Whitepaper) website located at View Source